Trial intelligence / Profile preview

Methylphenidate for Cocaine Dependence

NCT03090269Phase 2Withdrawn

Sponsor
ANRS
Start
Jun 2018
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of methylphenidate in cocaine dependence, sponsored by ANRS. Planned start Jun 2018; status: withdrawn.

02

Drugs

methylphenidate
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT03090269.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03090269.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call